ZIMV · Zimvie Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $116.66M | $112.00M | - | $103.22M | $116.81M | $118.19M | - | $202.87M | $224.90M | $225.43M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | $5.66M | $5.37M | - | $6.93M | $6.58M | $6.70M | - | $11.46M | $13.23M | $15.37M |
| SG&A | $59.57M | $58.98M | - | $57.31M | $62.38M | $60.33M | - | $117.35M | $128.48M | $127.97M |
| Total Operating Expenses | $115.37M | $111.22M | - | $108.06M | $123.50M | $120.93M | - | $219.05M | $246.72M | $241.55M |
| D&A | - | $8.65M | - | - | - | $8.43M | - | - | - | $32.63M |
| Operating Income | $1.29M | $780.0K | - | ($4.84M) | ($6.69M) | ($2.73M) | - | ($16.18M) | ($21.82M) | ($16.13M) |
| Interest Expense | $3.84M | $4.05M | - | $4.83M | $5.07M | $4.37M | - | $9.21M | $9.01M | $8.97M |
| Income Tax | $4.12M | $3.07M | - | ($688.0K) | $2.77M | $4.07M | - | ($20.36M) | ($6.85M) | $3.97M |
| Net Income | ($3.95M) | ($1.47M) | - | ($2.28M) | ($4.01M) | ($7.76M) | - | ($5.09M) | ($23.37M) | ($29.97M) |
| EPS - Basic | ($0.14) | ($0.05) | - | ($0.08) | ($0.15) | ($0.29) | - | ($0.19) | ($0.89) | ($1.14) |
| EPS - Diluted | ($0.14) | ($0.05) | - | ($0.08) | ($0.15) | ($0.29) | - | ($0.19) | ($0.89) | ($1.14) |
Balance Sheet
| Line item | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $70.18M | $66.75M | $74.97M | $66.81M | $78.60M | $43.53M | $71.51M | $75.45M | $66.21M | $66.41M |
| Accounts Receivable | $84.52M | $76.69M | $65.21M | $69.58M | $70.53M | $68.93M | $65.17M | $153.95M | $168.12M | $175.00M |
| Inventory | $84.45M | $77.67M | $75.02M | $77.09M | $71.83M | $77.23M | $79.60M | $213.74M | $227.53M | $231.08M |
| Accounts Payable | $41.68M | $31.54M | $32.96M | $27.40M | $27.16M | $26.95M | $27.79M | $51.31M | $59.42M | $52.59M |
| Current Assets | $260.21M | $250.66M | $257.29M | $265.67M | $273.85M | $455.14M | $482.88M | $497.62M | $507.38M | $504.17M |
| Total Assets | $758.22M | $745.78M | $753.67M | $782.95M | $789.79M | $1.17B | $1.21B | $1.51B | $1.56B | $1.59B |
| Current Liabilities | $109.61M | $117.14M | $133.94M | $136.64M | $141.12M | $169.65M | $173.61M | $171.22M | $189.74M | $196.53M |
| Long-term Debt | $220.79M | $220.62M | $220.45M | $220.28M | $235.11M | $502.06M | $508.80M | $515.53M | $522.27M | $521.99M |
| Total Liabilities | $345.42M | $350.66M | $371.97M | $376.31M | $395.69M | $783.28M | $795.85M | $797.72M | $832.70M | $844.46M |
| Stockholders' Equity | $412.80M | $395.12M | $381.71M | $406.64M | $394.10M | $388.33M | $409.49M | $710.20M | $727.84M | $743.60M |
| Retained Earnings | ($472.06M) | ($468.11M) | ($466.64M) | ($454.87M) | ($452.59M) | ($448.57M) | ($440.81M) | ($105.96M) | ($100.87M) | ($77.50M) |
Cash Flow
| Line item | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | ($13.91M) | - | - | - | ($11.51M) | - | - | - | ($7.20M) |
| Investing Cash Flow | - | ($1.95M) | - | - | - | ($4.14M) | - | - | - | ($5.83M) |
| Financing Cash Flow | - | ($1.14M) | - | - | - | ($1.44M) | - | - | - | ($10.94M) |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | 1.1% | 0.7% | - | -4.7% | -5.7% | -2.3% | - | -8.0% | -9.7% | -7.2% |
| EBITDA margin | - | 8.4% | - | - | - | 4.8% | - | - | - | 7.3% |
| Net margin | -3.4% | -1.3% | - | -2.2% | -3.4% | -6.6% | - | -2.5% | -10.4% | -13.3% |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | 4.9% | 4.8% | - | 6.7% | 5.6% | 5.7% | - | 5.6% | 5.9% | 6.8% |
| SG&A / Revenue | 51.1% | 52.7% | - | 55.5% | 53.4% | 51.0% | - | 57.8% | 57.1% | 56.8% |
| Effective tax rate | 2449.4% | 191.8% | - | - | - | - | - | - | - | - |
| Return on assets | -0.5% | -0.2% | - | -0.3% | -0.5% | -0.7% | - | -0.3% | -1.5% | -1.9% |
| Return on equity | -1.0% | -0.4% | - | -0.6% | -1.0% | -2.0% | - | -0.7% | -3.2% | -4.0% |
| Return on invested capital | 0.1% | 0.1% | - | -0.6% | -0.8% | -0.2% | - | -1.0% | -1.4% | -1.0% |
| Liquidity | ||||||||||
| Current ratio | 2.37 | 2.14 | 1.92 | 1.94 | 1.94 | 2.68 | 2.78 | 2.91 | 2.67 | 2.57 |
| Quick ratio | 1.60 | 1.48 | 1.36 | 1.38 | 1.43 | 2.23 | 2.32 | 1.66 | 1.47 | 1.39 |
| Cash ratio | 0.64 | 0.57 | 0.56 | 0.49 | 0.56 | 0.26 | 0.41 | 0.44 | 0.35 | 0.34 |
| Leverage | ||||||||||
| Debt / Equity | 0.53 | 0.56 | 0.58 | 0.54 | 0.60 | 1.29 | 1.24 | 0.73 | 0.72 | 0.70 |
| Debt / Assets | 0.29 | 0.30 | 0.29 | 0.28 | 0.30 | 0.43 | 0.42 | 0.34 | 0.33 | 0.33 |
| Debt / EBITDA | - | 23.38 | - | - | - | 88.11 | - | - | - | 31.63 |
| Interest coverage | 0.3x | 0.2x | - | -1.0x | -1.3x | -0.6x | - | -1.8x | -2.4x | -1.8x |
| Equity multiplier | 1.84 | 1.89 | 1.97 | 1.93 | 2.00 | 3.02 | 2.94 | 2.12 | 2.14 | 2.14 |
| Liabilities / Assets | 0.46 | 0.47 | 0.49 | 0.48 | 0.50 | 0.67 | 0.66 | 0.53 | 0.53 | 0.53 |
| Efficiency | ||||||||||
| Asset turnover | 0.15 | 0.15 | - | 0.13 | 0.15 | 0.10 | - | 0.13 | 0.14 | 0.14 |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | 264d | 250d | - | 246d | 220d | 213d | - | 277d | 273d | 283d |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -0.1% | -5.2% | - | -49.1% | -48.1% | -47.6% | - | -15.3% | -4.1% | -4.3% |
| Revenue CAGR (3y) | -20.8% | -22.0% | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | - | - | - | 70.1% | 69.4% | 83.1% | - | 3.0% | -1.3% | 50.6% |
| Net income growth (YoY) | 1.7% | 81.0% | - | 55.1% | 82.8% | 74.1% | - | - | -393.0% | -16.8% |
| EPS growth (YoY) | 6.7% | 82.8% | - | 57.9% | 83.1% | 74.6% | - | 83.6% | -169.7% | -16.3% |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 4.7% | 1.7% | -6.8% | -42.7% | -45.9% | -47.8% | -46.0% | -49.4% | -4.8% | -49.3% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2021-12-31.
Business segments
$2.02B totalSegment Total$1.01B · 50.0%
Spine$540.30M · 26.8%
Dental$468.50M · 23.2%
Peer comparison
Same SIC group: Dental Equipment & Supplies
Comparing ZimVie Inc. against the 5 most active filers in the same SIC group.